The Diagnostic Value of Oxidative Stress Products in Pulmonary Embolism

Basit Öğe Kaydı
dc.authorwosid, Osman/AGR-7980-2022
dc.authorwosid, osman/HRD-6024-2023
dc.contributor.authorBatmaz, Emrah
dc.contributor.authorEdis, Ebru Cakir
dc.contributor.authorEskiocak, Sevgi
dc.contributor.authorHatipoglu, Osman Nuri
dc.contributor.authorKaya, Sabriye
dc.date.accessioned2024-06-12T11:11:54Z
dc.date.available2024-06-12T11:11:54Z
dc.date.issued2011
dc.departmentTrakya Üniversitesien_US
dc.description.abstractObjective: The aim of our study is to show the oxidative stress in pulmonary embolism by detecting the levels of ischemia modified albumin (IMA), advanced oxidation protein product (AOPP) and malondialdehyde (MDA) in patients with pulmonary embolism. Material and Method: 39 patients, who were dagnosed with pulmonary embolism in the Emergency Service or Thoracic Diseases Polyclinic of the Trakya University Faculty of Medicine between September 1, 2008 and March 31, 2009, and 39 healthy volunteers were included in the study. IMA, AOPP and MDA levels were studied. T-test and Mann Whitney and X-2 tests were applied in independent samples. A value of p<0.05 was accepted as statistically significant. Results: There was no significant difference between the two groups in terms of age, height, and weight. The difference in the AOPP levels of the two groups was not significant. The difference in the serum albumin levels of the two groups was found significant (p<0.001). The difference in levels of IMA after being corrected according to the albumin levels of the two groups was not significant. MDA levels of the two groups showed a significant difference (p=0.032). Conclusion: AOPP levels in patients with pulmonary embolism were not found different but, the increases of MDA levels were significant. We suggest using albumin-adjusted IMA levels to interpret IMA levels more correctly. We need more studies about using IMA levels as an indicator for diagnosis of pulmonary embolism.en_US
dc.identifier.doi10.5152/ttd.2011.23
dc.identifier.endpage104en_US
dc.identifier.issn1302-7808
dc.identifier.issn1308-5387
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-80052052469en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage100en_US
dc.identifier.urihttps://doi.org/10.5152/ttd.2011.23
dc.identifier.urihttps://hdl.handle.net/20.500.14551/22975
dc.identifier.volume12en_US
dc.identifier.wosWOS:000421721200004en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.publisherBilimsel Tip Publishing Houseen_US
dc.relation.ispartofTurkish Thoracic Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectOxidative Stressen_US
dc.subjectPulmonary Embolismen_US
dc.subjectIschemia-Modified Albuminen_US
dc.subjectMalondialdehydeen_US
dc.subjectAdvanced Oxidation Protein Producten_US
dc.titleThe Diagnostic Value of Oxidative Stress Products in Pulmonary Embolismen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu